Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.91 USD | +2.45% | +5.47% | +32.91% |
Financials (USD)
Sales 2024 * | 584M | Sales 2025 * | 596M | Capitalization | 1.31B |
---|---|---|---|---|---|
Net income 2024 * | 116M | Net income 2025 * | 144M | EV / Sales 2024 * | 2.53 x |
Net Debt 2024 * | 167M | Net cash position 2025 * | 42.16M | EV / Sales 2025 * | 2.12 x |
P/E ratio 2024 * |
13.9
x | P/E ratio 2025 * |
11.1
x | Employees | 197 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.96% |
Latest transcript on Collegium Pharmaceutical, Inc.
1 day | +2.45% | ||
1 week | +5.47% | ||
Current month | +11.44% | ||
1 month | +11.20% | ||
3 months | +32.91% | ||
6 months | +83.04% | ||
Current year | +32.91% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 01-12-31 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 17-05-30 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 21-05-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 14-12-31 |
Gino Santini
BRD | Director/Board Member | 66 | 12-07-23 |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 29 M€ | -0.55% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 40.91 | +2.45% | 362,415 |
24-03-26 | 39.93 | -0.57% | 335,558 |
24-03-25 | 40.16 | +1.11% | 273,351 |
24-03-22 | 39.72 | +0.15% | 319,417 |
24-03-21 | 39.66 | +2.24% | 669,779 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.91% | 1.31B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.67% | 210B | |
+0.94% | 210B | |
-6.79% | 201B | |
-3.51% | 157B |